LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Exo is combining nanoscale piezoelectric material with semiconductors to innovate ultrasound technology
Exo recently completed a Series B round worth $40M with backing from 7 investors, including Action Potential Venture Capital, Fiscus Ventures, and Reimagined Ventures. With this recent fundraising round, the company has raised over $87M. The company is expecting to make its handheld ultrasound technology available in Q1 2021. Major competitors in the ultrasound market include GE Healthcare, Philips, and Siemens Healthineers.
Aerin Medical completes $48M in equity financing
The company develops and commercializes minimally invasive therapies for the treatment of nasal airway obstruction. In March 2020, the company received 510(k) clearance from the FDA for its second product, the Rhinaer Stylus, for the treatment of chronic rhinitis. Key strategics in the ENT devices market include Medtronic, Neurent Medical, and Stryker.
Orthopedic biofilm infection elimination technology is in development at Garwood Medical Devices
The BioPrax Platform uses a small needle inserted through the skin to contact orthopedic implants and deliver low voltage energy to eliminate implant surface biofilms. The company recently announced it had raised $4M in a Series C round to support additional preclinical testing. To-date Garwood Medical Devices has raised over $11M to develop its BioPrax Platform.
Neurescue is developing a computer-aided aortic occlusion catheter to redirect blood flow to the brain and heart
The company’s Neurescue device simplifies the REBOA (resuscitative endovascular balloon occlusion of the aorta) process using computer-aided pressure-limited filling and intelligent safety feedback to alert healthcare providers of proper insertion. Neursecue is currently seeking clinical and strategic partners. Major competitors in the cardiovascular devices market include Abbott, Getinge, and Teleflex.
Sonavex is detecting and preventing clot formatting with its bioresorbable implant technology
The EchoSure system is a two-part platform to allow healthcare providers to monitor clot formation following surgical anastomosis. The technology has received 510(k) clearance from the FDA. Other competitors offering blood flow and vessel patency monitoring solutions include Baxter, Cook Medical, and Medistim.
Bodyport is bringing clinical-grade cardiac monitoring to the patient
The Bodyport Scale is a biomarker-driven “virtual clinic” that allows healthcare providers to monitor cardiac function from a patient’s home. The company recently raised $11.2M in an August 2020 Series A funding round. The investment will help the company commercialize its cardiac monitoring technology. With this recent funding round, that company has raised approximately $15.8M.
LensGen raises $10M to support a pivotal FDA clinical study for its intraocular lens
The company is developing a fluid-optic intraocular lens for the treatment of cataracts and presbyopia. To-date the company has raised $52M, with the company seeking to raise an additional $10M in Bridge Financing. Key strategics in the ophthalmic devices market include Alcon, Bausch & Lomb, and Johnson & Johnson.
Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Start-Up Tracker.